These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39082333)

  • 1. Development of a Novel Prognostic Panel for Colorectal Cancer Based on Cancer Functional Status, and Validation of STC2 as a Promising Biomarker.
    Liu X; Wei N; Chen H
    Front Biosci (Landmark Ed); 2024 Jul; 29(7):245. PubMed ID: 39082333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
    Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
    Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
    Zhong R; Zhan J; Zhang S
    Appl Biochem Biotechnol; 2024 Jul; 196(7):3891-3913. PubMed ID: 37792175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of STC2 gene silencing on colorectal cancer cells.
    Li Q; Zhou X; Fang Z; Pan Z
    Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
    Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
    Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
    Lin C; Sun L; Huang S; Weng X; Wu Z
    Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
    Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
    World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.
    Hashemzadeh S; Arabzadeh AA; Estiar MA; Sakhinia M; Mesbahi N; Emrahi L; Ghojazadeh M; Sakhinia E
    Med Oncol; 2014 Oct; 31(10):237. PubMed ID: 25234931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning.
    Wen B; Chen J; Ding T; Mao Z; Jin R; Wang Y; Shi M; Zhao L; Yang A; Qin X; Chen X
    Sci Rep; 2024 Aug; 14(1):18734. PubMed ID: 39134603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
    Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
    J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
    Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
    BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.